Evaluation of the Effectiveness and Safety of Mesenchymal Stem Cell Treatment in Fistulising Crohn's Disease: An International Real‐Life Retrospective Multicentre Cohort Study
2024; Wiley; Linguagem: Inglês
10.1111/apt.18359
ISSN1365-2036
AutoresP Bacsúr, Dana Shaham, Zuzana Šerclová, Tamás Resál, B Farkas, Patrícia Sarlós, Pál Miheller, Nitsan Maharshak, Meir Zemel, Ariella Bar‐Gil Shitrit, Shlomo Yellinek, Anita Bálint, Anna Fábián, Renáta Bor, Zsófia Bősze, Emese Ivány, Zoltán Szepes, Klaudia Farkas, Illés Tóth, György Lázár, Kateřina Vlková, A Tremerova, Petra Zuskova, Szabolcs Ábrahám, Tamás Molnár,
Tópico(s)Diverticular Disease and Complications
ResumoPerianal fistulas of Crohn's disease (CD) create a significant burden on patients' lives. However, the efficacy and safety of adipose-derived mesenchymal stem cell treatment are contradicting, and real-world evidence is lacking.
Referência(s)